New Deal
Peter Hebert
Managing Partner at LUX CAPITAL MANAGEMENT
Investor
Deal Bio
Senti Biosciences
8VC
£77m
13 dealmakers
Latch
Ts Innovation Acquisitions Corp
£1,139m
51 dealmakers
Evolv Technology
Tony Ressler
£995m
43 dealmakers
BENCHLING
Menlo Ventures
£145m
11 dealmakers
SHAPEWAYS
Union Square Ventures
£295m
45 dealmakers
Eikon Therapeutics
The Column Group
£106m
6 dealmakers
Dyno Therapeutics
Gv (google Ventures)
£71m
10 dealmakers
Anduril Industries
Andreessen Horowitz
£319m
21 dealmakers
Genvid Holdings
Atreides Management
£81m
15 dealmakers
RAMP
Thrive Capital
£220m
19 dealmakers
SAILDRONE
Standard Investment
£72m
Fiddler Ai
Insight Partners
£22m
CHRONOSPHERE
Addition Ventures
£147m
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.